Targeting Telomere Integrity Enhances Radiosensitivity and Reveals Adaptive DNA Damage Response Vulnerabilities in Diffuse Midline Glioma
En palabras de los autores
Diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG), remains one of the most lethal pediatric malignancies, with limited durable benefit from radiotherapy (RT) due in part to adaptive DNA damage response (DDR) mechanisms. Here, we investigated whether targeting telomere integrity with the telomerase substrate analogue 6-thio-2'-deoxyguanosine (6-thio-dG; THIO) could induce therapeutically exploitable DNA damage in patient-derived DIPG models. THIO selectively suppressed DIPG cell proliferation while sparing telomerase-negative normal diploid fibroblasts and induced telomere dysfunction, as evidenced by increased telomere dysfunction-induced foci (TIFs), {gamma}H2AX accumulation, G2/M checkpoint arrest, and apoptosis. In orthotopic DIPG xenografts, THIO increased intratumoral TIF formation, suppressed tumor growth, and prolonged survival. Transcriptomic profiling further revealed activation of cellular stress-response pathways and downregulation of E2F genes, mitotic, and metabolism-associated gene programs. Mechanistically, THIO-induced progressive genomic and telomeric damage was associated with sequential activation of ATM and ATR signaling, consistent with engagement of adaptive DDR pathways. Combining THIO with ionizing radiation (IR) produced synergistic antitumor effects across three independent DIPG models representing distinct H3 mutation subtypes, with increased G2/M accumulation, genomic and telomeric DNA damage, and apoptotic cell death. In vivo, THIO combined with IR significantly improved therapeutic efficacy and prolonged median survival compared with monotherapy, including RT alone. Notably, pharmacologic inhibition of ATM or ATR attenuated THIO-induced checkpoint arrest and increased apoptosis, implicating DDR checkpoint signaling as an adaptive survival dependency following telomere damage. Collectively, these findings identify telomere-directed DNA damage as a promising therapeutic approach for DMG and provide a mechanistic rationale for combining THIO with RT and DDR checkpoint inhibition.
Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.